About Bioverge
Bioverge is a private company based in San Francisco, California. It has reported $1,512,000 raised in three offerings on Form D since May 2023. Its chief executive is Neil Littman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 7, 2022 | May 8, 2023 | $148,500fully sold | 4 | $37,125 | SAFE NotesRule 506(b) | Form D ↗ |
| May 5, 2020 | May 5, 2023 | $775,000fully sold | 21 | $36,905 | SAFE NotesRule 506(b) | Form D ↗ |
| Dec 3, 2018 | May 4, 2023 | $588,500of $600K target | 23 | $25,587 | SAFE NotesRule 506(b) | Form D ↗ |
| Total, three offerings | $1,512,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Bioverge's Form D filed May 8, 2023.
NL
Neil Littman
CEO and director
RG
Richard Gibb
Executive officer